CordovaCann (LVRLF) Convertible Debt (2012 - 2020)
CordovaCann (LVRLF) recorded quarterly Convertible Debt of $779169.7 in Q1 2020, down 17.48% quarter-over-quarter from $944202.8 in Q4 2019, and up 101.91% on a YoY basis from $385905.8 in Q2 2019.
CordovaCann (LVRLF) Convertible Debt (2012 - 2020) Analysis & Trends
CordovaCann's Convertible Debt history runs 3 years deep, the most recent figure standing at $779169.7 for Q1 2020.
- In Q1 2020, Convertible Debt rose 101.91% year-over-year to $779169.7; the TTM figure through Mar 2020 stood at $779169.7 (up 101.91% YoY), while the FY2019 annual figure was $412907.8, changed N/A from the prior year.
- Convertible Debt was $779169.7 for Q1 2020 at CordovaCann, down from $944202.8 in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $944202.8 in Q4 2019 to a low of $385905.8 in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | CordovaCann | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 779,169.69 |
| Dec 31, 2019 | 944,202.76 |
| Sep 30, 2019 | 902,349.08 |
| Jun 30, 2019 | 408,424.95 |
| Mar 31, 2019 | 385,905.79 |
| Dec 31, 2012 | 105,846.54 |
| Sep 30, 2012 | 102,459.91 |
| Jun 30, 2012 | 97,393.34 |